Duplex scanning allows selective use of arteriography in the management of patients with severe lower leg arterial disease  by Koelemay, Mark J.W. et al.
This included conservative treatment, PTA, and a
femoropopliteal bypass operation, whereas in approxi-
mately half of the patients scheduled for tibial or pedal
bypass operation, arteriography was still considered
mandatory. Similar recommendations were made by other
authors.16,17
In April 1997 we implemented a management strategy
a priori on the basis of DS and performed iaDSA only in
cases where DS was inconclusive or the surgeon felt
uncomfortable making a decision without arteriography.
The aim of this study was to evaluate the safety of this
strategy and to compare the immediate and 2-year clinical
outcome with our previous results.
PATIENTS AND METHODS
Patients. The study protocol was approved by the
Medical Ethics Committee of our hospital. All consecutive
patients with severe claudication, ischemic rest pain, or tis-
sue loss between April 1997 and September 1998 were eli-
gible. Patients with acute ischemia, those with extensive
tissue necrosis implying obligatory major amputation, or
those who were referred for a bypass operation after diag-
nostic arteriography had been performed elsewhere were
excluded. Patients were also excluded if DS identified sig-
nificant aortoiliac lesions amenable for PTA or surgical
reconstruction.
Duplex scanning (DS) is accurate for assessment of the
aortoiliac and femoropopliteal arteries.1,2 Several studies
have confirmed its reliability to guide percutaneous trans-
luminal angioplasty (PTA) of the iliac and femoral arteries
or an aortofemoral bypass operation in patients with clau-
dication.3-8 Although in some studies the diagnostic accu-
racy of DS for assessment of the infrapopliteal arteries was
low compared with arteriography,9,10 others found DS to
be accurate11-13 or even to be capable of detecting more
patent crural arteries.14
After a comparative study of DS and pulse-generated
runoff (PGR) with intra-arterial digital subtraction
angiography (iaDSA) for assessment of the popliteal and
cruropedal arteries in 120 patients with severe lower leg
ischemia, we concluded that 59% of such patients could be
managed solely on the information of DS and PGR.15
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Purpose: Until April 1997 we routinely performed intra-arterial digital subtraction angiography (iaDSA) in all patients
with severe lower leg ischemia requiring intervention. After a comparative study of duplex scanning (DS), pulse-
generated runoff, and iaDSA of the lower leg arteries, we postulated that management could be based on DS/pulse-
generated runoff in 59% of patients. We prospectively evaluated the safety of such a noninvasive workup strategy.
Methods: All consecutive patients referred with severe lower leg ischemia between April 1997 and September 1998 were
eligible. Management was based on DS with iaDSA being performed only on indication. Complications within 30 days
and 12- and 24-month patency, survival, and limb salvage rates were recorded and compared with historical controls.
Results: A total of 125 limbs in 114 patients were evaluated (74% rest pain or tissue loss). In 97 (78%) of 125 limbs,
management was based on DS. It comprised conservative treatment (n = 33, 0% after iaDSA), percutaneous translu-
minal angioplasty (n = 25, 16% iaDSA), femoropopliteal bypass graft (n = 29, 17% iaDSA), femorotibial bypass graft
(n = 29, 62% iaDSA), and other surgical procedures (n = 8, 4% iaDSA). Overall, the mortality within 30 days was 4%
(5/114), and 2-year survival was 83%. Two-year primary and secondary patency and limb salvage rates were 75%, 93%,
and 93% after a femoropopliteal bypass operation, respectively. One-year primary and secondary patency and limb sal-
vage rates were 35%, 73%, and 74%, respectively, after a femorocrural bypass operation. There were no differences in
patient characteristics, indication for specific treatment, and immediate and intermediate term outcome between the
study and reference population.
Conclusion: In a vascular unit with wide expertise in DS of the lower leg arteries, management of patients with severe
lower leg ischemia can be based on DS in most patients without negative effects on clinical outcome within 30 days
and at 2-years’ follow-up. (J Vasc Surg 2001;34:661-7.)
Duplex scanning. Two vascular technologists with
more than 3 years’ experience with infrapopliteal DS per-
formed the examinations, using a Hewlett Packard Sonos
2000 scanner (Hewlett Packard, Andover, Mass). The
bilateral aortoiliac and ipsilateral femoropopliteal tracts
were examined with 3.5- and 5.5-MHz imaging transduc-
ers and 3.5-MHz Doppler probes, respectively. The crural
and pedal arteries were examined with 4.5- and 7.5-MHz
imaging linear array transducers and 3.7- and 5.5-MHz
Doppler probes, respectively. The aortoiliac and femoro-
popliteal tract, anterior tibial (AT), dorsalis pedis, and
deep plantar arteries were scanned with the patient supine.
The popliteal, peroneal, posterior tibial, and common
plantar arteries; the tibioperoneal trunk; and the origin of
the AT were examined with the patient in the lateral decu-
bitus position.
The hemodynamic significance of lesions in the aor-
toiliac and femoropopliteal tract was graded by peak sys-
tolic velocity (PSV) ratios, calculated as the PSV in the
stenosis divided by the PSV in the prestenotic or post-
stenotic region. Significant lesions were identified by a
PSV ratio of 2.5 or more, for a stenosis >50%, or the
absence of Doppler signals in case of an occlusion. The
supragenicular and infragenicular popliteal arteries,
tibioperoneal trunk, and the crural and pedal arteries were
graded as: 
2: for no or minor vessel wall irregularities seen on B-
mode imaging and a fully patent lumen determined by
the presence of a color Doppler signal;
1: for severe vessel wall irregularities (B-mode), diffuse
narrowing (color Doppler or PSV changes detected by
pulsed Doppler scan) or an isolated stenosis (PSV ratio
≥ 2.5);
0: for occlusion indicated by a present vessel wall (B-
mode) but absent color and pulsed Doppler signal.
A segment with both stenosis and occlusion was
graded as occluded. If a segment was unable to be ade-
quately evaluated because of calcifications, for example,
DS was considered nondiagnostic. The location of any
abnormality or restoration of full patency of the vessel
below the upper rim of the patella was recorded in cen-
timeters.
Both technologists scored the findings without super-
vision of a vascular surgeon. All examinations were per-
formed according to the same tight protocol evaluated in
our index study, obviating the need for an adjudicating ref-
eree to review each study for uniformity and consistency.15
The technologists received continuous feedback on dis-
crepancies between DS and arteriography or findings dur-
ing the operation to ensure high-quality examinations.
Management. The DS results were recorded on an
anatomical diagram, which served as the basis for a treat-
ment plan. Management decisions were taken jointly by
the vascular surgeons and interventional radiologist and
comprised conservative treatment, PTA, and surgical revas-
cularization. Minor amputations (toe, transmetatarsal) or
drainage of abscesses were considered to be conservative
treatment. The indication for PTA was a PSV ratio of 2.5
or more or a 10-cm or less occlusion in the superficial
femoral artery (SFA). Selected patients with SFA occlu-
sions more than 10 cm were treated with subintimal angio-
plasty.18, 19 Indications for surgery were a diffusely stenotic
or totally occluded SFA, multiple stenoses in the SFA, or
restenosis of the SFA after PTA. The indication for a
femoropopliteal bypass operation was a patent supragenic-
ular or infragenicular popliteal artery with minor or no ves-
sel wall irregularities and at least one fully patent artery to
the foot. In such cases arteriography was not performed
The indication for a crural or pedal bypass operation was an
occluded SFA and diffuse luminal narrowing, an isolated
stenosis, or occlusion of the infragenicular popliteal artery.
An iaDSA was not indicated if DS detected a single, fully
patent crural or pedal artery to the foot. If DS detected
multiple (partially) patent crural arteries, the artery with no
or minor vessel wall irregularities was chosen as recipient
artery. Patients were liberally referred for iaDSA if DS was
inconclusive. Autologous venous material, even if har-
vested arm veins were required, was always preferred as
graft material. The distal anastomosis site was always cho-
sen as distally as possible to a segment with uninterrupted
good quality runoff, especially in patients with gangrene of
the foot. Completion angiography was performed to assess
the quality of the outflow below the reconstruction.
Intraoperative DS was not used for quality control.
Arteriography. Selective iaDSA was performed by
means of an anterograde puncture technique of the com-
mon femoral artery after DS excluded significant aortoiliac
lesions. Nonionic contrast (iohexol 350 mg iodium/mL;
Nycomed, Oslo, Norway) was administered by continuous
mechanical injection at the volume of 10 mL in 2 seconds,
with the catheter tip positioned as distally as possible in the
SFA. Biplane views were obtained in all patients.
Follow-up. Patients treated with a bypass operation
were entered into a DS surveillance protocol. Duplex
scans were made 4 to 6 weeks postoperatively and after 1
year if the PSV ratios at the proximal and distal anasto-
moses were 2.5 or less. In case DS detected changes sug-
gestive of graft stenosis (PSV ratio between 2.5 and 4.0),
scans were repeated after 3 months. When symptoms
recurred or the PSV ratio progressed to 4.0 or more,
patients were referred for arteriography and PTA of the
bypass or surgical revision. Follow-up data were collected
from case files, the general practitioner, or death certifi-
cates when patients had died after discharge from our out-
patient clinic, and are complete until June 2000.
Reference population. The clinical outcome of the
current series was compared with a reference population
that comprised 113 consecutive patients with severe lower
leg ischemia who participated between February 1995 and
March 1997 in the comparative study of DS, PGR, and
iaDSA for assessment of the popliteal and cruropedal out-
flow tract.15 Inclusion and exclusion criteria for the refer-
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ence study and the current study were identical. From this
cohort, seven patients treated with primary amputation
were excluded. Six patients underwent bilateral examina-
tions. All patients underwent iaDSA, which served as the
basis for treatment plans, formulated by the same vascular
surgeons and interventional radiologist. These patients
were also entered into the same surveillance protocol and
had follow-up data collected until the beginning of 1999.
Outcome measures. The complication and mortality
rates within 30 days after intervention, as well as reinter-
vention, patency, limb salvage and survival rates at 12 and
24 months’ follow-up, were recorded and calculated
according to the revised standards proposed by the Joint
Council of the Society for Vascular Surgery.20 A graft was
considered patent if DS detected no stenosis or occlusion.
Primary patency was defined as an uninterrupted patent
graft without additional interventions. Assisted primary
patency was defined as graft patency maintained by prophy-
lactic intervention. Secondary patency was defined as an
occluded graft with patency restored by thrombolysis,
thrombectomy, or PTA or surgical revision of one of the
graft’s anastomoses. Limb salvage was defined as the time
from intervention until a below- or above-knee amputation.
Analysis. Where appropriate, the χ2 test or Fisher
exact test was used for comparison of differences between
groups for categorical data, and the Student t test or one-
way analysis of variance for continuous data. Cumulative
survival, patency, and limb salvage rates were estimated
with the Kaplan-Meier life-table method, with SEs calcu-
lated with Greenwood’s formula. Differences between
groups were tested with the Mantel-Haenszel log-rank
test. A 2-tailed P value less than .05 indicated statistical
significance. All calculations were performed with SPSS
8.0 for Windows (Chicago, Ill). Risk ratios were calculated
with Epi Info 6.04b (Centers for Disease Control and
Prevention, Atlanta, Ga).
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RESULTS
Patients. From a total of 141 eligible patients, 27
were excluded. Nine patients were referred for a bypass
operation after arteriography performed elsewhere, 6
patients had an acute arterial occlusion, 3 patients had
extensive tissue necrosis that necessitated primary below-
knee amputation, 8 patients were operated on after arteri-
ography without DS because of logistical constraints, and
1 patient was included in a concurrent clinical trial. This
left 114 patients for evaluation. Eleven patients underwent
bilateral examinations, yielding a total of 125 examined
limbs. Table I lists the clinical characteristics. In the 113
patients from our reference population, 119 limbs were
evaluated.
Success of DS and subsequent management. DS
was diagnostic in all aortoiliac and femoropopliteal tracts.
In four patients DS could not visualize all popliteal or
crural arteries, which made iaDSA necessary a priori. Table
II lists the definitive treatment in both populations and
the proportion of iaDSA.
Thirty-three patients were treated conservatively.
Fourteen had claudication with multilevel lesions. Surgical
treatment would imply femorocrural bypass graft, for
which we consider claudication an inappropriate indica-
tion. Four patients with rest pain and 15 with tissue necro-
sis had no options for revascularization. This was mainly
because DS detected severe stenoses or occlusions within
the very distal tibial or pedal arteries, whereas the aortoil-
iac and femoropopliteal arteries showed no abnormalities.
Thirteen such patients had a fully patent popliteal artery
with 1 (n = 5), 2 (n = 5), or 3 (n = 3) fully patent crural
arteries to the level of the ankle. Three patients had all
crural arteries occluded at the ankle and foot. Six patients
underwent a minor amputation.
Twenty-five patients were treated with PTA. Four SFA
occlusions were treated with subintimal angioplasty.
Table I. Characteristics of 114 patients included in the current study and 113 patients from the reference population
Characteristic Current (n = 114) Reference (n = 113) P value
Median age (range), y 72 (33-96) 72 (27-95) .56
Claudication 32 (26%) 21 (17%)
Rest pain 42 (34%) 41 (34%) .29*
Tissue loss 51 (40%) 57 (48%)
Male sex 71 (62%) 69 (61%) .96
Diabetes 39 (34%) 47 (42%) .31
Smoking (current or prior) 42 (37%) 49 (43%) .39
Hypertension (taking medication) 33 (29%) 43 (38%) .18
Hyperlipidemia (taking medication) 10 (9%) 11 (10%) .98
Coronary artery disease (angina, AMI, PTCA, CABG) 32 (28%) 40 (35%) .56
Cerebrovascular disease (TIA, stroke) 20 (18%) 22 (19%) .84
Prior intervention (PTCA, bypass graft, endarterectomy) 58 (50%) 59 (52%) .42
Prior ipsilateral infrainguinal PTA 22 (18%) 23 (19%) .72
Prior ipsilateral infrainguinal bypass graft 23 (19%) 24 (20%) .89
*P value for differences in proportion claudication, rest pain, and tissue loss between study populations.
AMI, Acute myocardial infarction; PTCA, percutaneous transluminal coronary angioplasty; CABG, coronary artery bypass graft; TIA, transient ischemic
attack, PTA, percutaneous transluminal angioplasty.
Twenty-one patients were referred for PTA on the basis of
DS. The preinterventional angiogram showed no other
lesions than those identified with DS and did not alter the
planned intervention. The indication for iaDSA in the
other four patients undergoing PTA was nondiagnostic
DS due to calcifications in two patients, poor wound heal-
ing in a patient with an unrecognized tibioperoneal trunk
stenosis, and unclear in one.
One patient scheduled for femoropopliteal bypass
graft died of acute myocardial infarction while waiting to
undergo an operation. Femoropopliteal bypass operation
was based on DS in 24 (83%) of 29 patients without unex-
pected findings at operation. Six patients had undergone a
prior ipsilateral infrainguinal bypass operation. Vein grafts
were used in three and polytetrafluoroethylene (PTFE) in
nine patients with the distal anastomosis at the above-knee
popliteal artery. Vein grafts were used in 16 patients with
the distal anastomosis at the below-knee popliteal artery,
and PTFE was used in one. The indication for iaDSA was
a nondiagnostic DS due to a calcified popliteal artery in 1
patient, unclear in 2 patients, and a recent PTA of the iliac
or femoral arteries in 2 patients. Twenty-nine patients
underwent a femorocrural bypass operation. Ten patients
had undergone a prior ipsilateral infrainguinal bypass
operation. In 11 patients with popliteal artery occlusion,
DS detected a fully patent single crural artery. These
patients underwent an uncomplicated femorocrural bypass
operation without arteriography and without unexpected
findings at completion angiography. The remaining 18
patients were operated on after iaDSA because DS
detected multiple patent or partially patent crural arteries.
DS suggested a treatment identical to the definitive treat-
ment in 14 (78%) of 18 of these patients. In 15 patients,
the in situ greater saphenous vein (GSV) was used as con-
duit. In three patients the in situ GSV was extended by the
contralateral GSV. In six patients the reversed contralateral
GSV was used, and one patient had a graft composed of
arm veins. Four patients had a PTFE bypass graft. In two
patients, the graft was anastomosed jointly on the peroneal
artery and vein, and in the other two, the graft was
extended with the GSV or lesser saphenous vein.
Two patients scheduled for a bypass graft to the pero-
neal artery were explored only. In both, the quality of the
artery was considered too poor to insert a graft. Two
patients with a femorofemoral crossover bypass graft were
treated by revision of this bypass graft. All four patients
were not excluded from this study because the definitive
treatment plan could be made only after a complete eval-
uation with DS or iaDSA.
In the patients treated surgically, the median
ankle/brachial index rose from 0.38 (range, 0-1.10) pre-
operatively to 0.90 (range, 0-1.21) after the operation
(data available for 56 patients). Hemodynamic success,
defined as a rise in the ankle/brachial index more than
0.1, was obtained in 46 (82%) of 56 reconstructions.20
Indications for treatment. Table III lists the respec-
tive treatments and symptoms, age, and number of previ-
ous interventions. Our new strategy did not induce
differences in treatment and indication for treatment com-
pared with our reference population. The mean ages of
patients treated with PTA and operation were 74 and 69
years, respectively (P = .02). Patients treated surgically had
undergone more previous interventions (41/67 [61%]),
than patients treated with PTA (9/25 [36%], P = .03).
The same pattern was found in our reference population.
No statistical differences were found for severity of symp-
toms, age, and number of previous interventions between
both populations, within each treatment modality.
Complications within 30 days after start of treat-
ment. Table IV lists the complications within 30 days
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Table II. Definitive management in limbs of the current and reference study populations
Definitive management Current n (%) iaDSA n (%)* Reference n (%)
Conservative 33/125 (26%) 0/33 (0%) 21/119 (18%)
PTA 25/125 (20%) 4/25 (16%) 31/119 (26%)
SFA 18 18
Popliteal/crural 7 13
Operation 67/125 (54%) 27/67 (40%) 67/119 (56%)
Femoropopliteal bypass graft 29 5/29 29
Above-knee 12 8
Below-knee 17 21
Femorocrural bypass graft 29 18/29 37
TP trunk 4 –
Anterior tibial 6 5
Posterior tibial 9 16
Peroneal 7 10
Pedal 3 6
Endarterectomy SFA 4 2/4 1
Exploration only 2 1/2 –
(Revision) fem-fem 2 1/2 –
Died before operation 1 1/2 –
*IaDSA n refers to the proportion of patients treated after diagnostic arteriography.
fem-fem, Femorofemoral crossover bypass graft; iaDSA, intra-arterial digital subraction angiography; SFA, superficial femoral artery; TP, tibioperoneal.
after the start of treatment. The overall mortality rate was
4%. The four early graft occlusions after femoropopliteal
bypass operation occurred in patients operated on solely
on the basis of DS. Graft patency was maintained by revi-
sion of the proximal anastomosis in two patients and by
thrombectomy in two patients, 1 day postoperatively.
After femorocrural bypass operation, despite a patent
bypass graft, three patients underwent a major amputation
because of extensive necrosis, and two patients because of
early graft occlusion. Three of these patients were oper-
ated after iaDSA. Review of the completion angiographies
could not help explain the graft failures in the patients
who had undergone an operation, according to DS. The
incidence and nature of early complications were compa-
rable to the reference population.
Follow-up. Table V lists the clinical outcome at fol-
low-up. Follow-up, with a median duration of 24 months
(range, 0-38 months) was complete for 113 (99%) of
114 patients. One patient was lost to follow-up after emi-
gration. The proportion of additional interventions
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within 2 years, necessary to maintain limb salvage or graft
patency, is also listed in Table V for each treatment
modality. One patient treated conservatively needed a
PTA and another one a femoropopliteal bypass graft. The
2-year limb salvage rate after PTA was 94%. Five patients
needed additional interventions to prevent amputation.
Table V also lists the estimated 1- and 2-year patency and
limb salvage rates after femoropopliteal bypass operation.
Data for femorocrural bypass operation are listed for only
6 and 12 months’ follow-up because the SE of survival
exceeded 10% after this time.
Follow-up data were complete for 111 (98%) of 113
reference population patients. Follow-up data were miss-
ing for one patient who moved abroad and for a second
patient who was jailed. The median follow-up was 24
months (range, 0-44 months). We did not find any differ-
ences in mortality, limb salvage, reintervention, and
patency rates between the two populations at 12 and 24
months’ follow-up. Although not statistically significant,
the primary patency rate after femorocrural bypass opera-
Table III. Clinical characteristics specified for definitive management in limbs of both study populations
Definitive management Current n (%) Reference n (%) P value
Conservative 33/125 (26%) 21/119 (18%)
Claudication 14 7 .31*
Rest pain 4 6
Tissue necrosis 15 8
Mean age (range), y 70 (33-96) 64 (28-91) .20
Previous intervention 14 11 .45
PTA 25/125 (20%) 31/119 (27%)
Claudication 3 4 .22*
Rest pain 9 5
Tissue necrosis 13 22
Mean age (range), y 74 (37-92) 75 (43-96) .81
Previous intervention 9 10 .49
Surgery 67/125 (54%) 67/119 (56%)
Claudication 15 10 .51*
Rest pain 29 30
Tissue necrosis 23 27
Mean (range), y 69 (45-95) 68 (33-95) .70
Previous intervention 41 38 .53
*P value for differences in proportions severity of symptoms.
Table IV. Complications within 30 days after start of treatment
Complication Current Reference Risk ratio P value
Mortality rate 5/114 (4%) 8/113 (7%) 0.62 (0.21-1.84) .56
Conservative 1/33 (3%) 1/21 (5%)
PTA 0/25 (0%) 4/31 (12%)
Surgery 3/66 (5%) 3/67 (4%)
Graft occlusion after bypass operation
Femoropopliteal 4/29 (14%) 2/29 (7%) 2.0 (0.40-10.0) .67
Femorocrural 2/29 (7%) 4/37 (11%) 0.64 (0.13-3.64) .90
Amputation after bypass operation
Femoropopliteal 0/29 (0%) 1/29 (0%) NA 1.0
Femorocrural 5/29 (17%) 4/37 (11%) 1.59 (0.47-5.41) .49
P value for differences between groups.
NA, Not applicable; PTA, percutaneous transluminal angioplasty.
tion was lower in the patients treated according to our
new workup strategy.
DISCUSSION
The aim of this study was to evaluate the safety of
management of patients with severe lower leg ischemia
according to DS with selective use of iaDSA. A diagnostic
DS was obtained in 97% of patients, and clinical decision
making was allowed without iaDSA in 78% of the patients’
limbs. As expected, most of the femoropopliteal bypass
operations could be based on DS alone, if a fully patent
infragenicular popliteal artery and at least one patent
crural artery to the foot were detected. If DS detected a
single patent crural vessel, a femorocrural bypass operation
could safely be performed. An iaDSA was necessary before
a femorocrural bypass operation when DS detected multi-
ple (partially) patent crural arteries. Although iaDSA
altered the treatment plan suggested by DS in only four of
18 patients, it is mandatory to perform arteriography in
these cases. Our findings are in line with the experience of
Mazzariol et al.21 In their study, DS could supplant arteri-
ography in 51 of 58 consecutive operations, which
included 21 femoropopliteal and 23 infrapopliteal bypass
grafts.21 In a subgroup analysis the same investigators
reported successful infrapopliteal bypass operations in 26
(93%) of 28 patients.22 Most of these patients (79%) had
a single runoff artery.
The current study demonstrates that DS can also
guide treatment modalities other than surgery. Referral for
PTA on the basis of DS was appropriate in 21 (84%) of 25
patients. We recognize that PTA is routinely preceded by
preinterventional arteriography, but this never changed
the intended treatment. DS could also safely guide deci-
sions for conservative treatment. It can be argued that
patients treated conservatively do not need to undergo a
complete DS study, which is only necessary if an interven-
tion is intended. However, the decision for conservative
management could only be made after DS detected multi-
level disease in patients with claudication that would
require a femorocrural bypass operation. We consider
claudication an inappropriate indication for such recon-
structions. The choice for conservative treatment in 13
patients with rest pain or tissue loss and a patent
femoropopliteal tract and at least one fully patent crural
artery may be debatable. However, the fact that only two
(6%) patients treated conservatively needed to undergo a
PTA or bypass operation within 1 year justifies this deci-
sion.
The implementation of our new workup did not influ-
ence clinical outcome. The number and nature of compli-
cations within 30 days were comparable to our previous
results. Moreover, we found no differences in limb sal-
vage, reintervention, and survival rates between the two
populations during follow-up. Although the success of
femoropopliteal bypass operation is in line with other
studies, our results for femorocrural and femoropedal
bypass operations may seem disappointing.23 The early
graft failure rate after femorocrural bypass operation was
7% and 11% in the current and reference study, respec-
tively. Also, the amputation rates were high, although in
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Table V. Patency, survival, and limb salvage rates at follow-up
Current Reference
1 y 2 y 1 y 2 y P value* 
Whole population
Survival 89% (3%) 83% (4%) 81% (4%) 74% (5%) .05
Reintervention rate
Conservative 6% 6% 11% 11% .55
PTA 24% 24% 16% 16% .51
Surgery 24% 25% 24% 27% .84
Intervention
PTA
Limb salvage 95% (4%) 94% (6%) 86% (7%) 86% (8%) .12
Femoropopliteal bypass graft
Primary patency 79% (8%) 75% (12%) 66% (10%) 58% (13%) .14
Assisted primary patency 86% (6%) 86% (9%) 72% (9%) 64% (13%) .10
Secondary patency 93% (5%) 93% (7%) 85% (7%) 80% (11%) .19
Limb salvage 93% (5%) 93% (6%) 92% (4%) 92% (6%) .73
6 mo 1 y 6 mo 1 y
Femorocrural bypass graft
Primary patency 55% (11%) 35% (11%) 74% (8%) 54% (10%) .59
Assisted primary patency 74% (9%) 58% (11%) 74% (8%) 58% (10%) .63
Secondary patency 83% (8%) 73% (10%) 94% (4%) 85% (7%) .34
Limb salvage 78% (8%) 74% (9%) 89% (6%) 82% (7%) .82
All values in parentheses are SEs of proportion event free survival.
*P values for log-rank test.
half of the patients this was obligatory because of progres-
sive tissue necrosis despite a patent bypass graft. We can
only speculate about the causes for these findings. It may
be that our patient selection is not strict enough and that
we must decide earlier that a femorocrural reconstruction
is deemed to fail. One third of the procedures were redo
operations, which, in combination with the suboptimal
conduit in some cases, might have influenced the primary
patency rates. Primary patency is an important parameter
in the qualitative assessment of the bypass operation.
However, from a clinical point of view, one cannot deny
the importance of secondary patency and limb salvage
rates, which in our population are comparable to other
series. Finally, it should be realized that it is difficult to
compare the results of different centers because factors
such as patient selection, comorbidity, and graft surveil-
lance may also influence outcome.
Using historical controls rather than a randomized
trial to compare outcome might obscure alternative expla-
nations for finding similar results. However, we have no
reason to assume that our indications for treatment and
the nature of treatment have changed within the two time
frames. This is supported by the comparable characteristics
of the two populations within the respective treatment
modalities. In addition, a large sample size would be
required to demonstrate an equal effectiveness of both
workup strategies in a study that can only be conducted as
a multicenter trial.
In summary, in a vascular unit with wide expertise in
DS of the lower leg arteries, the management of patients
with severe lower leg ischemia based on DS can provide a
substantial reduction in diagnostic arteriographies without
negative effects on clinical outcome.
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